EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 236 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2019. The put-call ratio across all filers is 4.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $336,000 | +17.1% | 6,436 | +8.4% | 0.01% | +9.1% |
Q2 2019 | $287,000 | -2.7% | 5,936 | +1.7% | 0.01% | -8.3% |
Q1 2019 | $295,000 | -14.7% | 5,836 | 0.0% | 0.01% | -25.0% |
Q4 2018 | $346,000 | -9.9% | 5,836 | 0.0% | 0.02% | +14.3% |
Q3 2018 | $384,000 | +30.2% | 5,836 | 0.0% | 0.01% | +16.7% |
Q2 2018 | $295,000 | -3.9% | 5,836 | 0.0% | 0.01% | -7.7% |
Q1 2018 | $307,000 | +28.5% | 5,836 | +13.6% | 0.01% | +30.0% |
Q4 2017 | $239,000 | +39.8% | 5,136 | +21.2% | 0.01% | +25.0% |
Q3 2017 | $171,000 | +66.0% | 4,236 | +39.3% | 0.01% | +60.0% |
Q2 2017 | $103,000 | +134.1% | 3,042 | +102.8% | 0.01% | +150.0% |
Q1 2017 | $44,000 | -53.7% | 1,500 | -48.3% | 0.00% | -66.7% |
Q4 2016 | $95,000 | +4.4% | 2,900 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $91,000 | -35.0% | 2,900 | -12.1% | 0.01% | +200.0% |
Q2 2016 | $140,000 | -50.9% | 3,300 | -57.9% | 0.00% | -50.0% |
Q1 2016 | $285,000 | -10.9% | 7,840 | -2.0% | 0.00% | -20.0% |
Q4 2015 | $320,000 | – | 8,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |